AB Science SA (OTC:ABSCF) Financings

AB Science SA

Financings

RaiseDateIn US dollars
Private placement of new ordinary shares with share warrants attached (ABSA)
Closed: €14.2M raised · €0.61 a share · 1 warrant at €1 for 60 months
Buyers: Existing long-term investor (EUR 12 million); Stéphane Ledermann
Insiders: The CEO, Stéphane Ledermann, also contributed to the financing
Use of proceeds: Fund R&D programs, mainly AB8939 in acute myeloid leukemia, masitinib in ALS, and nearer-term value-creation projects
Aug 10, 2026US$16.4M
Private placement of new ordinary shares with share warrants attached (ABSA)
Announced: €3.2M · €0.94 a share · Warrants at €1.3 for 48 months · Maxim Group LLC
Dealers: Maxim Group LLC (lead)
Use of proceeds: Finance ongoing activities, with a focus on the clinical development of the AB8939 program
Apr 29, 2026US$3.74M
Private placement of new ordinary shares with share warrants attached (ABSAs)
Closed: €2.8M raised · €1.13 a share · Warrants at €1.72 for 60 months
Use of proceeds: Finance ongoing activities, focusing on clinical development of AB8939: finish phase 1 and launch an AML expansion study
Oct 17, 2025US$3.27M
Private placement of new ordinary shares with share warrants attached (ABSAs)
Closed: €2.55M raised · €1.12 a share · Warrants at €1.71 for 60 months
Use of proceeds: To finance ongoing activities, with a focus on the clinical development of the AB8939 program
Aug 4, 2025US$2.94M
Private placement of new ordinary shares with share warrants attached (ABSAs)
Closed: €1.93M raised · €1.17 a share · Warrants at €1.78 for 60 months
Use of proceeds: Finance ongoing activities, with a focus on clinical development of the AB8939 program
Jul 8, 2025US$2.25M
Private placement of new shares
Closed: €1.8M in the latest tranche · €1.17 a share · Warrants at €1.79 for 60 months · Maxim Group, LLC
Dealers: Maxim Group, LLC (lead)
Use of proceeds: Strengthens the cash position and covers financing needs in 2025 and beyond the next 12 months
May 23, 2025

Read by 6ix AI from the company's releases

AB Science SA (OTC:ABSCF) Financings | 6ix